Chandrananimycin E

Details

Top
Internal ID 8ab87964-22d1-4734-b7a3-ef939205ca19
Taxonomy Organoheterocyclic compounds > Benzoxazines > Phenoxazines > N-substituted phenoxazines
IUPAC Name 2-hydroxy-N-[3-hydroxy-10-(2-hydroxyacetyl)-8-(hydroxymethyl)phenoxazin-2-yl]acetamide
SMILES (Canonical)
SMILES (Isomeric)
InChI InChI=1S/C17H16N2O7/c20-6-9-1-2-14-11(3-9)19(17(25)8-22)12-4-10(18-16(24)7-21)13(23)5-15(12)26-14/h1-5,20-23H,6-8H2,(H,18,24)
InChI Key MBUFQJRRHNNNEY-UHFFFAOYSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C17H16N2O7
Molecular Weight 360.30 g/mol
Exact Mass 360.09575085 g/mol
Topological Polar Surface Area (TPSA) 140.00 Ų
XlogP -0.90
Atomic LogP (AlogP) 0.58
H-Bond Acceptor 7
H-Bond Donor 5
Rotatable Bonds 4

Synonyms

Top
2-hydroxy-N-[3-hydroxy-10-(2-hydroxyacetyl)-8-(hydroxymethyl)phenoxazin-2-yl]acetamide
2-hydroxy-N-(3-hydroxy-10-(2-hydroxyacetyl)-8-(hydroxymethyl)phenoxazin-2-yl)acetamide
RefChem:125012
CHEBI:217153

2D Structure

Top
2D Structure of Chandrananimycin E

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.6773 67.73%
Caco-2 - 0.8957 89.57%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability - 0.6000 60.00%
Subcellular localzation Nucleus 0.7917 79.17%
OATP2B1 inhibitior - 0.7025 70.25%
OATP1B1 inhibitior + 0.8871 88.71%
OATP1B3 inhibitior + 0.9451 94.51%
MATE1 inhibitior - 0.7200 72.00%
OCT2 inhibitior - 0.9314 93.14%
BSEP inhibitior + 0.6743 67.43%
P-glycoprotein inhibitior - 0.7878 78.78%
P-glycoprotein substrate - 0.8011 80.11%
CYP3A4 substrate - 0.5195 51.95%
CYP2C9 substrate - 0.6095 60.95%
CYP2D6 substrate - 0.7907 79.07%
CYP3A4 inhibition - 0.8608 86.08%
CYP2C9 inhibition - 0.6278 62.78%
CYP2C19 inhibition - 0.8808 88.08%
CYP2D6 inhibition - 0.8675 86.75%
CYP1A2 inhibition - 0.7473 74.73%
CYP2C8 inhibition + 0.4564 45.64%
CYP inhibitory promiscuity - 0.8616 86.16%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.8700 87.00%
Carcinogenicity (trinary) Non-required 0.6636 66.36%
Eye corrosion - 0.9904 99.04%
Eye irritation - 0.7247 72.47%
Skin irritation - 0.8121 81.21%
Skin corrosion - 0.9523 95.23%
Ames mutagenesis - 0.5600 56.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6830 68.30%
Micronuclear + 0.9300 93.00%
Hepatotoxicity - 0.5250 52.50%
skin sensitisation - 0.9005 90.05%
Respiratory toxicity + 0.7222 72.22%
Reproductive toxicity + 0.8000 80.00%
Mitochondrial toxicity + 0.8250 82.50%
Nephrotoxicity - 0.5820 58.20%
Acute Oral Toxicity (c) III 0.6892 68.92%
Estrogen receptor binding + 0.7623 76.23%
Androgen receptor binding + 0.6233 62.33%
Thyroid receptor binding - 0.5294 52.94%
Glucocorticoid receptor binding + 0.8153 81.53%
Aromatase binding + 0.7968 79.68%
PPAR gamma + 0.8844 88.44%
Honey bee toxicity - 0.9245 92.45%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity - 0.5200 52.00%
Fish aquatic toxicity - 0.5792 57.92%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 95.70% 98.95%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 94.22% 94.45%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 90.32% 91.11%
CHEMBL3060 Q9Y345 Glycine transporter 2 88.55% 99.17%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.08% 96.09%
CHEMBL1806 P11388 DNA topoisomerase II alpha 86.28% 89.00%
CHEMBL3401 O75469 Pregnane X receptor 84.09% 94.73%
CHEMBL1293249 Q13887 Kruppel-like factor 5 81.93% 86.33%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 80.15% 94.33%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 80.07% 94.00%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 132557480
LOTUS LTS0216603
wikiData Q77500270